Your browser doesn't support javascript.
loading
Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
Dovey, Oliver M; Cooper, Jonathan L; Mupo, Annalisa; Grove, Carolyn S; Lynn, Claire; Conte, Nathalie; Andrews, Robert M; Pacharne, Suruchi; Tzelepis, Konstantinos; Vijayabaskar, M S; Green, Paul; Rad, Roland; Arends, Mark; Wright, Penny; Yusa, Kosuke; Bradley, Allan; Varela, Ignacio; Vassiliou, George S.
Affiliation
  • Dovey OM; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Cooper JL; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Mupo A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Grove CS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Lynn C; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia.
  • Conte N; PathWest Division of Clinical Pathology, Queen Elizabeth II Medical Centre, Nedlands, Australia.
  • Andrews RM; Leukemia and Stem Cell Biology Group, Division of Cancer Studies, Department of Haematological Medicine, King's College London, London, United Kingdom.
  • Pacharne S; Sample Phenotype Ontology Team, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Tzelepis K; Institute of Translation, Innovation, Methodology, and Engagement, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Vijayabaskar MS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Green P; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Rad R; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Arends M; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
  • Wright P; Department of Medicine II, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.
  • Yusa K; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.
  • Bradley A; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Varela I; Department of Haematology, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom; and.
  • Vassiliou GS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom.
Blood ; 130(17): 1911-1922, 2017 10 26.
Article in En | MEDLINE | ID: mdl-28835438
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Mutation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Mutation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Blood Year: 2017 Document type: Article Affiliation country: Country of publication: